Tags
Blog

'Neuroscience Institute' posts

Swedish to Host Live Stream of Woman’s First Time Hearing in Five Years, Plus Live Text Chats

CochlearImplantMrsDay.jpgSEATTLE, Oct. 9, 2012 - On Tuesday, Oct. 2, Eleanor Day, 79, underwent a cochlear implant procedure at Swedish/Cherry Hill by Dr. Douglas Backous, medical director of the Center for Hearing and Skull Base Surgery. Her procedure was the world’s first live-instagrammed and live-tweeted cochlear implant (hearing restoration) surgery (click here to see a recap). This Wednesday, Oct. 10, Swedish will live stream Mrs. Day’s cochlear implant activation, in which she will potentially hear her husband’s voice without the help of hearing aids for the first time in five years. The Days have been married for 60 years.

Swedish-Affiliated Neurologist Interviewed about Results of New Study on 'Mini' Strokes and Clot-Busting Drugs

SEATTLE, Oct. 8, 2012 - A short video news story on new research around the use of clot-busting dugs to treat 'mini' strokes was recently posted on the national news sites EverydayHealth.com and AOL.com. The two-minute long piece features an interview with William Likosky, M.D., medical director of Swedish Neuroscience Institute's Stroke Program, as well as a local stroke patient.

Swedish to Host World’s First Live-Instagrammed, Live-Tweeted Hearing Restoration Surgery as Part of Month-Long Educational Web Series on Hearing Loss

SEATTLE, Sept. 26, 2012 - Swedish Medical Center and Douglas Backous, M.D., medical director of the Center for Hearing and Skull Base Surgery at the Swedish Neuroscience Institute, will host the world’s first live-instagrammed and live-tweeted cochlear implant (hearing restoration) surgery on Tuesday, Oct. 2 at 7 a.m. Pacific Time (PT).

Swedish Contributes to New Treatment Option for Multiple Sclerosis

 On September 12, 2012, the Food and Drug Administration (FDA) approved teriflunomide for the treatment of multiple sclerosis (MS). Teriflunomide (AUBAGIO) is a once-daily pill for the treatment of relapsing forms of MS. Led by Dr. Lily Jung Henson, the Swedish Neuroscience Institute was among several clinical sites that tested the drug. Results of the research showed that teriflunomide can lessen MS disease activity. Specifically, it behaves similarly to injectable therapies by slowing MS relapse frequency, the rate of disability and MRI activity.

The safety profile, however, is more challenging than ....

Taking Control of Your Brain Health: Class is Sept. 29 at Swedish/Issaquah

First you can’t remember where you left your keys. Then an acquaintance’s name just won’t come to you.

Is it just old age or is it a memory disorder? Sometimes it’s hard to tell and not knowing can be equally as frustrating as forgetfulness itself.

The best way to head off memory loss and to figure out if that is in fact what you’re experiencing is to talk with your doctor and discuss your concerns. Of course, it’s not always easy or convenient to get to the doctor. Dr. Lily Jung-Henson, of the Swedish Neuroscience Institute, holds free community classes that cover these issues and allow you the chance to get some of your questions answered.

Partnering with Dr. Arpan Waghray, Medical Director for Behavioral Health at Swedish, and other members of the Swedish Rehab Services team in Issaquah, Dr. Jung-Henson will be holding a class called “Taking Control of Your Brain Health” on Saturday, September 29.

This free class will be held at the Swedish/Issaquah hospital in the Highlands from 10:30 a.m. to 12:30 p.m. and will help you answer questions such as:

Issaquah Press Publishes Article, 'Issaquah Brothers Become Brain Surgeons for a Day'

SEATTLE, Aug. 29, 2012 - The Issaquah Press posted an article on their web site today headlined 'Issaquah brothers become brain surgeons for a day' about two Issaquah brothers who were among those invited by the Swedish Neuroscience Institute to become brain surgeons for a day on Aug. 24.

Brain Cancer Research in Seattle Leads to New Treatment Options for Patients

SEATTLE, Aug. 27, 2012 – Since its opening in 2008, the Ben & Catherine Ivy Center for Advanced Brain Tumor Treatment (the Ivy Center) at Swedish Medical Center's Neuroscience Institute has led the expansion drive of major research projects and expanded treatment options for patients living with brain cancer in the Pacific Northwest and throughout the world. The Ivy Center was founded in 2008 to create a world-class treatment and research facility focused on delivering excellent patient care and advancing progress toward more effective treatments for brain cancer.

Results 71-77 of 100